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Background make them complementary to mutational analysis [6, 7].
What pathways impose global structure and pattern to an For example, their application can be limited to short
organ? For the vertebrate heart, the key visible step is windows of time, and their targets extend beyond those
chamber morphogenesis, the fashioning of atrium and accessible to gene disruption alone. These abilities have
ventricle. The proper orientation of these two functionally proved particularly useful in elucidating pathways in sin-
different contractile units guarantees unidirectional flow gle cells. Colchicine, cycloheximide, and phobol ester,
of blood beginning with the first beat of the heart. Cham- among others, have proven the power of this approach.
ber form thereafter becomes the substrate upon which However, unlike mutagenesis, in which the functional
the rest of heart development is superimposed. deficit may be ascribed to a specific gene, it is conceivable
that, especially in vivo, a small molecule may perturb a
large set of processes, with widespread biological deficitsOver recent years, much has been learned about the mo-
reflecting this concatenation. Thus, we felt that we wouldlecular mechanisms that drive the acquisition of character-
initially focus upon chemical effects that disrupt attributesistic atrial and ventricular cell fates [1, 2]. However, steps,
of organ patterning in a manner identical to mutations. Ifboth embryological and molecular, that fashion their
these two very different perturbants (chemical and ge-higher order structure have proved to be more elusive, in
netic) do not affect the same pathway, they could revealpart because, unlike cell fate decisions, they can be stud-
a key step in development at their point of biologicalied meaningfully only in the living organism.
convergence.
In the zebrafish, one successful approach for identifying
In this report, we demonstrate that the small moleculesteps of cardiogenesis is genetic screening [3–5]. A second
concentramide, identified by a chemical screen in zebra-approach, which we explore here, is the use of large-scale
fish, alters the global organization of the zebrafish heart.screens for small molecule modulators of development.
We find that, after exposure to concentramide, both atrialSmall molecules that permeate the zebrafish and disrupt
and ventricular cells are generated, and chambers form,specific developmental pathways can be identified. Such
reagents have certain advantages that, in principle, might but the ventricle is generated within the atrium. Here, we
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Figure 1analyze the morphology of the heart in zebrafish embryos
harboring the heart-and-soul (has) mutation, previously iso-
lated from a genetic screen because it causes small hearts,
and we find that it causes a nearly identical phenotype.
The phenotypic similarity between the hearts of cencen-
tramide-treated and has mutant embryos suggests that
there is an early step of chambermorphogenesis perturbed
both by concentramide and has. We demonstrate that
has mutants harbor a point mutation in an atypical PKC,
PKC, which is known to be involved in cell polarity and
the integrity of epithelial sheets in Caenorhabditis elegans
and Drosophila [8, 9]. Consistent with the role of PKC
in C. elegans and Drosophila, we show that its mutation in
zebrafish disrupts cell polarity, epithelial layer integrity
in many tissues, and ultimately heart patterning. In con-
trast, the small molecule concentramide does not appear
to affect cell polarity or epithelial layer integrity but rather
alters anterior-posterior (AP) patterning in the anterior
end of the developing zebrafish, including the heart field.
A small molecule that alters heart patterning. (a) The structure ofWhat is shared between the effects of the small molecule concentramide. (b) A lateral view of the mushroom-shaped heart of
concentramide and mutation of PKC is a reversal in a live, concentramide-treated embryo 30 hpf. The atrium is indicated
with an “A”, and the ventricle is indicated with a “V”. (c) A timethe order of fusion of the anterior and posterior heart
course of concentramide effectiveness. Black bars indicate theprimordia, suggesting that this step is critical to proper
developmental time periods during which groups of embryos were
chamber formation and alignment. The complementarity immersed in water containing concentramide. An “x” indicates that
of genetic and chemical approaches can therefore facilitate treatment during the indicated time period alters the wild-type brain
or heart phenotypes. An “o” indicates that the wild-type phenotypedissection of even relatively late and higher order organo-
was observed. Blue and pink boxes mark the critical periods fortypic decisions.
development of the brain and heart phenotypes, respectively.
Results
Concentramide specifically modulates a biological
pathway involved in heart patterning hearts that do not sustain circulation. It appears that both
Zebrafish embryos have recently been shown to be ame- the atrium and ventricle form and beat in a coordinated
nable to high-throughput screening to identify small mol- manner in these fish, but the ventricle forms in the center
ecules that perturb developmental processes [10]. In one of the atrium, as shown in Figures 2e and 2f. The result
such screen, we exposed developing zebrafish embryos is a heart in which the atrium and ventricle form two
to small molecules from a large, diverse chemical library. concentric rings, the inner ring composed of the ventricle
Visual inspection of the transparent embryos was used to and the outer ring composed of the atrium. From the
identify small molecules that affect the global patterning dorsal view, the heart looks like a bullseye (Figure 2d),
of the heart. One of these small molecules is a biaryl and from the lateral view, it looks like an inverted mush-
compound containing an acrylamide moiety that we call room in which the ventricle forms the stalk of the mush-
concentramide (Figure 1a, originally identified as library room and the atrium surrounds and covers the ventricle
number 32P6 [10]). like the top of the mushroom (Figure 1b).
Normally, by 24 hr postfertilization (hpf), the heart tube Several observations suggest that concentramide is a
assembles in themidline, with the atrium positioned ante- highly specific modulator of a particular molecular path-
rior to the ventricle and slightly displaced toward the left way critical to heart patterning. Concentramide is very
(Figure 2a), and blood flow is driven from the atrial to the potent, with an ED50 of about 2 nM. More importantly,
ventricular end, first by persistalsis and then by sequential higher doses of concentramide do not appear to cause
chamber contractions. By 30 hpf, chambers are clearly additional side effects. Concentramide causes virtually
demarcated (Figure 2b, using cardiac myosin light chain the same phenotype when used at a concentration of 6
2, cmlc2, to label both chambers) and express different M as it does when used at a concentration of 6 nM,
genes, as shown in Figure 2c (ventricle-specific myosin suggesting that it modulates a specific molecular target
at least 1000 times more potently than it modulates otherheavy chain and atrial-specific antibody S46).
proteins affecting visible developmental processes. The
effect of concentramide on cardiovascular developmentEmbryos exposed to concentramide develop compact
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Figure 2 mental processes. To identify the developmental stage at
which concentramide disrupts heart patterning decisions,
we added concentramide to the water of developing em-
bryos at various times. As shown in Figure 1c, embryos
treated at any time prior to 14 hpf exhibit the concentric
chamber morphology at 24 hpf, whereas embryos treated
after 17 hpf exhibit the wild-type heart morphology at 24
hpf. Repeating the experiment with more precise staging
revealed that concentramide must be present before the
14-somite stage (approximately 15 hpf) to induce the con-
centric chambermorphology. Therefore, a developmental
event occurring at the 14-somite stage is critical for heart
patterning and is disrupted by the small molecule con-
centramide.
The hearts of concentramide-treated embryos
phenocopy heart-and-soul mutants
heart-and-soul (has) is a mutation isolated in our large-scale
genetic screen [3]. The hearts of homozygous has mutant
embryos are small. We find here that, like those of con-Hearts from has mutant embryos phenocopy hearts from
centramide-treated embryos, the hearts of hasmutant em-concentramide-treated embryos. In situ hybridization was performed
with (a–c) wild-type, (d–f) concentramide-treated, and (g–i) has bryos have ventricular tissue within the atrium (Figure
embryos. The expression pattern of cardiac myosin light chain 2 2g–i). They manifest radial sequential contractions of the
(cmlc2) is shown for embryos (a,d,g) 24 hpf and (b,e,h) 30 hpf. The
atrium, then the ventricle. The hasmutant embryos, how-relative locations of the atrium (A) and the ventricle (V) were
confirmed by 7-m sagital sections of embryos in which the ventricle ever, also manifest defects in many tissues, including the
was prestained blue by in situ hybridization to ventricle-specific retina, kidney, gut, and brain. These defects are not pres-
myosin heavy chain (vmhc), (c,f,i) followed by staining of the atrium ent in concentramide-treated embryos. The brain of con-brown with the atrium-specific antibody S46. In (a), (d), and (g), the view
centramide-treated embryos does develop abnormally,is dorsal and anterior is oriented up. In all other frames, the view is
lateral and anterior is oriented toward the left. but treating embryos between 9 and 14 hpf eliminates
this brain defect while preserving the concentric heart
chamber phenotype (Figure 1c).Therefore, the heart phe-
notypes of concentramide-treated and has mutant em-
does not appear to be a result of general cytotoxicity. The bryos are very similar, but concentramide-treated embryos
development of concentramide-treated embryos is not appear to have fewer developmental defects elsewhere,
delayed relative to untreated siblings, and no increase in and the cardiac specificity of the phenotype can be in-
cell death is apparent. Concentramide also has no effect creased further by controlling the timing of concentramide
on the rate of the proliferation of yeast (data not shown) treatment.
or bromodeoxyuridine incorporation in mammalian cells
(P. A. Clemons and S. L. Schreiber, personal communica-
Heart-and-soul encodes atypical PKCtion). Given the potency of concentramide, its phenotypic
reproducibility over a broad concentration range, and the Given the phenotypic similarities between hearts from
rarity of the phenotype it produces (none of the 2000 has and concentramide-treated embryos, we reasoned that
other small molecules screened generates a similar pheno- cloning the has gene might provide molecular insight into
type), it is likely that concentramide is a specific modula- the process of heart patterning. Furthermore, cloning of
tor of a biological pathway responsible for heart pat- has might allow us to determine whether has and con-
terning. centramide influence heart patterning through similar or
distinct mechanisms. We mapped has by linkage analysis
with zebrafish SSR markers [11–13] and AFLP [14] to anA time window for concentramide effects
interval flanked by markers z8451 and z11023 of approxi-One advantage of small molecules over genetic mutations
mately 1.1 cM (see Figure 3a). These were used to initiatein studying a developmental process is that small mole-
a walk using YACs and BACs, which proceeded by endcules allow the process to bemodulatedwithmuch greater
cloning, refined mapping, and ultimately sequencing.temporal control. Small molecules can be added or washed
Genes identified as candidates for the mutation were as-away at any time during development, whereas genetic
sayed by in situ analysis and were assayed for cDNAmutations are generally present throughout development.
polymorphism by RT-PCR of wild-type and mutant RNAThis temporal control afforded by small molecules facili-
tates the identification of critical periods for develop- pools. The genes contained within the BACs are shown
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Figure 3 formed by another group that they had identified PKC
as the likely protein encoded by the has gene (S. Horne
and D. Stainier, personal communication). By sequencing
PKC from wild-type and mutant embryos, we confirmed
that both has alleles harbor mutations in the PKC-coding
sequence. The mutation in the m567 allele causes a pre-
mature stop codon after amino acid 518, and the mutation
in the m129 allele causes a premature stop codon after
amino acid 514 (Figure 3a). We determined the complete
genomic structure of the zebrafish PKC gene by shotgun
sequencing of BAC 23c14. It is comprised of 18 exons
spanning approximately 45 kb. We find PKC mRNA to
be expressed in a broad range of tissues (data not shown).
The C-terminal truncation of PKC does not appear to
destabilize the protein, since truncated protein is detected
by Western blot analysis of mutant embryos (Figure 3b).
However, truncation might be predicted to eliminate a
domain essential for PKC function, given that truncation
removes the predicted autophosphorylation site Thr556
and the conserved hydrophobic site Glu575 (Figure 3a).
Furthermore, C-terminal truncation of PKC or PKC
renders these related kinases catalytically inactive [15,
16]. In order to confirm the role of PKC mutation in the
phenotype, we injected antisense morpholino oligomers
complementary to the PKC translational start site. These
injections phenocopy the mutation entirely. The injected
embryos are indistinguishable at the gross morphological
level from the genetic mutants (Figure 3c), supporting
the idea that loss of the C-terminal 70 amino acids is
sufficient to eliminate gene function.
The heart-and-soul gene encodes PKC. (a) A map of the has interval The integrity of epithelia is affected by PKC mutation,
with the genomic structure of the zebrafish PKC gene. YAC and but not by treatment with concentramide
BAC clones are indicated by addresses beginning with “y” and “b”. PKC belongs to the large PKC family of kinases and,The BAC clone 23c14 was sequenced to determine the entire
with PKC, is classified as an “atypical” PKC [17]. Thegenomic structure of the has gene. From the partial sequence of the
BACs listed, a preliminary transcript map of the region was presumptive ortholog of PKC in C. elegans, PKC-3, colo-
determined (see Table 1). The zebrafish PKC gene comprises 18 calizes with Par3 and Par6 at the anterior pole of the one-
exons represented by vertical lines. The site of the mutations cell embryo [8, 18]. PKC-3 is necessary for the establish-associated with the m129 and m567 alleles is indicated with an
ment of embryonic polarity, and inactivation of PKC-3asterisk. The domain structure of PKC is also shown, including the
C2-like domain, pseudosubstrate (psub.) domain, C1 domain, and leads tomislocalization of the Par genes and a symmetrical
catalytic domain. The activation loop phosphorylation site (T404), first cell division. Drosophila possess only one atypical
autophosphorylation site (T556), and hydrophobic site (E575) are also
PKC (DaPKC) that also associates with a Par3-like proteinshown. A vertical line marks the truncation site for the has m129 and
(Bazooka) and is implicated in the control of cell polaritym567 alleles. (b) An anti-PKC Western blot of protein extracts from
wild-type embryos (WT), has mutant embryos (m567 /), and [9]. DaPKC mutants exhibit disordered epithelial lay-
siblings of has mutant embryos (m567 / & /). (c–e) Antisense ering, irregular cell shapes, and loss of epithelial cell polar-
disruption of PKC expression phenocopies the has mutation. (c)
ity, believed to be due to defects in cell adhesion. InWild-type embryos, (d) has embryos, and (e) wild-type embryos
vertebrate cells, PKC and PKC both localize to epithe-injected with a PKC antisense morpholino oligomer were
photographed live 2 days postfertilization. lial tight junctions and associate with a Par3-like protein
(ASIP) [19–22]. We therefore examined whether the has
mutation and concentramide treatment perturb epithelial
patterning and tight junctions, focusing upon the retina
in Table 1. The gene assignments are based on BLASTX and the kidney. The neural retina arises from an epithelial
alignments. sheet that is bordered by the lens on the basal surface
and by a second epithelial sheet (the retinal pigmented
epithelium, RPE) on the apical surface [23]. Prior to cellDuring the screening of candidate genes, we were in-
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Table 1
Candidate genes identified within the heart-and-soul interval.
BAC address Identified genes (GenBank accession number)
109f10/122n17 KIAA0670 protein/acinus (NP_055792)
membane-type 1 metalloproteinase precursor (AAD13803)
adaptin, gamma (NP_001119)
KIAA1416 protein, novel Helicase C-terminal domain and SNF2 N-terminal domain-
containing protein, similar to KIAA0308 (CAB57836)
ZPC domain-containing protein 2 (AAD38907)
zinc finger protein sal (AAB51127)
cerebellin 1 precursor (NP_004343)
RING finger protein (AAB05873)
152p21 unknown (NP_056541)
89i15 precerebellin-like protein (AAF04305)
23c14 PKC
transforming protein sno-N; chicken (I51298)
53c17 no genes detected by BLASTX (mostly repetitive)
differentiation, the nuclei of the neuroepithelial cells mi- of wild-type, has, and concentramide-treated embryos. As
in the retina, cell polarity appeared to be largely conservedgrate between the apical and basal surfaces of the epithe-
lium. During M-phase, cell nuclei localize to the apical in has kidneys (Figure 5a–c). The has kidneys did, how-
ever, exhibit irregularities in the shapes of epithelial cellssurface, adjacent to the neighboring RPE [24]. Beginning
at about 30 hpf, these neuroepithelial cells exit the cell and occasional gaps between cells (data not shown), con-
sistent with a defect in epithelial cell adhesion. We didcycle and differentiate into one of seven distinct cell types
[25, 26]. Each cell type then migrates to a specific layer not observe these defects in embryos exposed to con-
centramide. Similarly, concentramide does not cause ain the retina, resulting in a highly organized, laminar pat-
tern (see Figure 4a). loss of cell asymmetry or Par2 localization during the first
cell division in nematodes (data not shown). Therefore,
The has mutation causes disruption of the layering of the although concentramide treatment and PKC inactivation
both result in similar heart patterning phenotypes, con-neural retina and patchy loss of the RPE (Figure 4e).
centramide does not appear to inactivate zebrafish PKCThese defects resemble those noted previously in zebra-
or its nematode ortholog.fish bearing the mutations oko meduzy (ome) and mosaic
eyes (moe)[27, 28]. In has mutants, the severity of laminar
disruption correlates with the position and degree of RPE The molecular target of concentramide is involved
discontinuity, suggesting that the RPE epithelial defect in AP patterning
causes or exacerbates that of the neural retina. This would If the molecular target of concentramide does not affect
be concordant with the evidence that a normal RPE is the continuity of epithelial sheets as PKC does, by what
critical to lamination [29, 30] and the fact that the retinal sort of process might it influence heart patterning? Treat-
epithelium of hasmutants does manifest at least one attri- ment with concentramide appears to affect the relative
bute of proper apical-basal polarity in that the majority positions of several anatomical structures along the anterior-
of the mitotic nuclei localize correctly to the apical surface posterior (AP) axis. For example, the distance between
of the neuroepithelium (Figure 4b,d,f; 89% of M-phase Pax2.1-expressing cells in the eyes and at the midbrain/
nuclei from has embryos localize to the apical surface hindbrain boundary is reduced in concentramide-treated
embryos (Figure 6a–c). Perhaps more significantly, theversus 97% of nuclei from wild-type embryos). As a
cardiac myosin light chain 2 (cmlc2)-expressing cells ofmarker of tight junctions, we examined immunoreactive
the heart field are shifted rostrally in concentramide-zonula occludens (ZO-1), an integral tight junction pro-
treated embryos at the 18-somite stage. This shift is eventein, and found it to bemislocalized (Figure 4g–h). There-
more pronounced than the shift of themidbrain/hindbrainfore, loss of adhesion between RPE cells may be a cause
boundary. The heart field lies completely posterior toof retinal mispatterning in has mutants. Notably, retinas
the midbrain/hindbrain boundary in 18-somite wild-typefrom concentramide-treated embryos do not exhibit de-
embryos but is partially anterior to themidbrain/hindbrainfects in cell polarity (Figure 4d), RPE continuity, or lami-
boundary of 18-somite concentramide-treated embryosnation (Figure 4c)
(Figure 6d–e). The distance between the anterior edge
of the cmlc2-expressing field and the anterior extreme ofThe developing kidney is another structure composed of
highly polarized epithelial cells. We examined the distri- the embryo is about 40% greater in wild-type embryos
(3.1 	 0.2 arbitrary units, n 
 8) than in concentramide-bution of apical and basolateral proteins in the kidneys
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Figure 4 Figure 5
The effects of PKC inactivation and concentramide treatment on the
polarity of the zebrafish kidney. An apical kidney marker (3G8) was
used to stain kidneys of (a) wild-type, (b) concentramide-treated, and
(c) has embryos. Transverse 2-m sections of the pronephric duct
are shown.
of concentramide appears to play a role in AP patterning,
PKC is required for lamination, cell polarity, and epithelial cell-cell especially in the positioning of the heart field relative to
interaction in the retina. Transverse 5-m sections of (a–b) wild- the midbrain/hindbrain boundary, the notochord, and the
type, (c–d) concentramide-treated, and (e–f) has embryos were
anterior extreme of the embryo.stained with (a,c,e) hematoxylin-eosin 5 days postfertilization or with
(b,d,f) dapi 30 hpf. Arrowheads indicate mitotic nuclei. Zonula
occludens-1 localization in the retina is shown by 5-m transverse
sections following staining of (g) wild-type or (h) has embryos with PKC and the target of concentramide both influence
an anti-ZO-1 antibody. the fusion order of heart primordia
PKC and the molecular target of concentramide appear
to act via distinct cellular mechanisms, but modulation of
either results in a very similar change in the patterning
treated embryos (2.2 	 0.3 arbitrary units, n 
 12, Figure of the heart. To identify the commonalities between the
6f). The position of the heart field in has mutants (3.1 	 two mechanisms that allow such similar mispatterning of
0.3 arbitrary units, n 
 12) does not differ significantly the heart, we took advantage of the temporal control with
from the wild-type position. The concentramide-induced which small molecules can modulate biological processes.
shift in the heart field alters the location of the field As described above, we determined that embryos must
relative to signaling centers believed to participate in heart be treated with concentramide at or prior to the 14-somite
formation, including the notochord [31]. The posterior stage to cause formation of the ventricle within the atrium.
end of the heart field extends to the tip of the notochord From this observation, we conclude that a critical heart
or beyond in wild-type, 16-somite embryos (Figure 6g). In patterning process is initiated shortly after the 14-somite
concentramide-treated, 16-somite embryos, the posterior stage, and perturbation of this process results in the con-
end of the heart field remains anterior to the tip of the centric chamber phenotype observed in both has and con-
centramide-treated embryos. This allowed us to focus ournotochord (Figure 6h). Therefore, the molecular target
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Figure 6 Figure 7
The order of anterior and posterior heart field fusion. Dorsal views of
cmlc2 expression at the (a–c) 18-somite and the (d–f) 20-somite
stages. Expression patterns for (a,d) wild-type, (b,e) concentramide-
treated, and (c,f) has embryos are shown. Anterior is oriented up.
search for commonalities between has and concentramide-
treated embryos to this critical time period.
The generation of the primitive heart tube is accom-
plished by midline coalescence of the bilateral cardiac
primordial sheets. In the zebrafish, this coalescence first
generates a single midline cone, with its base on the yolk
[1, 32]. Subsequently, the cone tilts to assume a midline
AP orientation with the preventricular end oriented to-
ward the posterior, later swinging anteriorly as yolk is
resorbed.
We find that, normally, the generation of themidline cone
does not occur uniformly around the cone’s circumference
but rather progresses from posterior to anterior, with pos-
terior regions merging at the 18-somite stage and anterior
regions merging at the 20- to 22-somite stage. This step
Alterations in anterior-posterior patterning after treatment with is perturbed by both concentramide and the hasmutation.
concentramide. (a–c) In situ hybridization was used to show Pax2.1 In both has mutant embryos and concentramide-treated
expression in (a) untreated and (b) concentramide-treated 18-somite
embryos, there is a failure to merge the posterior endsembryos. The expression patterns have been false-colored blue for
(Figure 7a–c). Even by the 20-somite stage, when theuntreated embryos and red for concentramide-treated embryos. (c)
An overlay of images (a) and (b). Arrowheads indicate areas of anterior ends of the primordia begin to fuse normally, the
Pax2.1 expression at the midbrain-hindbrain boundary and in the otic posterior ends remain separated in the has and con-
placodes. In (a)–(c), the view is lateral and anterior is oriented toward
centramide-treated embryos (Figure 7d–f). Eventually,the left. (d–e) Double in situ staining of the heart field (F, cmlc2 probe)
and Pax2.1-expressing cells (arrowheads) in (d) untreated and (e) the posterior ends do fuse in has and concentramide-
concentramide-treated 18-somite embryos. Lateral view; anterior is treated embryos, just before the emergence of the concen-
oriented toward the left. (f) The distance between the anterior edge tric-chambered heart. Thus, a critical patterning decisionof the heart field, as defined by cmlc2 in situ staining, and the rostral
occurs at about the 16- to 18-somite stage that regulatesextreme of the zebrafish embryo were measured in wild-type (WT),
concentramide-treated (conc.), and has embryos at the 18-somite
stage. Error bars represent the standard error. (g–h) Double in situ
staining of the heart field (cmlc2) and the notochord (no tail, ntl probe)
expressing cells (arrowheads) in (i) untreated and (j) concentramide-in (g) wild-type and (h) concentramide-treated 16-somite embryos.
treated 20-somite embryos. Lateral view; anterior is oriented towardThe view is dorsolateral; anterior is oriented toward the left. Arrowheads
the left.mark the anterior extreme of the notochord. (i–j) Double in situ
staining of the heart field (F, cmlc2 probe) and -tropomyosin-
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the fusion order of the anterior and posterior ends of epithelium, and the kidney and fail to generate proper
lamination of the neural retina.the heart field. This process can be blocked either by
inactivation of PKC or by modulating the target of con-
How PKC deficiency causes epithelial disruption is de-centramide.
bated. In C. elegans and Drosophila, PKC is important to
the establishment of polar cell division in the one-celledDiscussion
embryo. In epithelia, PKC and its Drosophila orthologLike other complex biological processes, organogenesis
localize to tight junctions and adherens junctions, in mam-likely involves the cooperation of several biological path-
mals and flies, respectively [9, 22]. These sites of epithe-ways. To understand how organs form, experimental en-
lial cell-cell contact are required for maintaining cohesivetrance points to critical positions in those biological path-
epithelial sheets [20] and also for controlling the planeways are needed [33]. In the case of the vertebrate heart,
of epithelial cell division [37]. Loss-of-function DaPKCwe have been interested in identifying the pathways that
mutants in Drosophila exhibit multilayering of epitheliaorganize differentiated heart tissues into a precisely pat-
and gaps in epithelia [9], similar to the effects noted hereterned, functional structure. We have sought informative
in the RPE, neural retina, and renal epithelium. However,entrance points into these pathways via two complemen-
analysis of the has phenotype does not clarify which, iftary approaches, screening for genetic mutations and,
any, of these widespread epithelial deficits contribute tomore recently, screening for small molecules that affect
the cardiac phenotype, especially since neighboring epi-heart patterning in zebrafish.
thelia of the neural plate and gut are known to transmit
important signals to the developing heart [1].
There is no question that genetic screens can reveal both
the overall biological logic and specific key genes of devel- The small molecule concentramide causes the concentric
opmental design. However, gene mutation may be unin- heart chamber phenotype by a mechanism that does not
formative due to the redundancy of systems supporting involve widespread disruptions of epithelia. Epithelial
critical developmental events, or widespread deformity cell morphology appears normal in concentramide-treated
and early lethality due to effects distant from those of embryos, and no discontinuities in cell-cell contacts are
particular interest. In principle, some of these lacunae evident in the heart, RPE, or kidneys. Tight junctions
might be filled by a complementary chemical screen. localize properly in concentramide-treated retinas (data
These have additional benefits in that targets of small not shown), and lamination occurs normally. What con-
molecules need not even be proteins, and exposure to centramide appears to alter is the AP patterning of the
the compound can be temporally controlled with great anterior end of the embryo. Perhaps most significantly,
precision. the heart field is shifted rostrally in concentramide-treated
embryos, as are the otic placodes and the midbrain-hind-
In this report, we define a key step in heart formation by brain boundary. The developmental event affecting heart
its perturbation with a small molecule and a mutation. patterning that is modulated by concentramide occurs
This step is the proper alignment of the two cardiac cham- shortly after the 14-somite stage; treatment of embryos
bers just as the primitive heart tube assembles. Two per- after this stage does not affect heart patterning. This stage
turbants, the small molecule concentramide and the has of development coincides with the migration of the bilat-
mutation, elicit a previously undescribed chamber malal- eral heart primordia toward each other, prior to their fusion
ignment, in which the ventricle forms inside of the atrium. to form the heart tube.
This means that establishment of the cardiocyte cell fates
is largely accomplished, but the higher order assembly of It is at the critical stage of midline fusion of the bilateral
chamber structure is disrupted. heart primordia that the effects of has and concentramide
appear to converge. In both, the normal order of fusion
of the anterior and posterior ends of the heart field isWe find the has mutation to be in PKC. This gene has
been found to play roles in many processes including disrupted. In wild-type embryos, the posterior end of the
insulin-induced glucose uptake [34], the establishment heart field fuses first. Posterior fusion is delayed in has
of embryonic asymmetry in worms [8], and Ras-mediated mutants and concentramide-treated embryos, and the an-
reorganization of actin stress fibers [35, 36]. One role of terior end fuses first.
possible relevance here is its importance in the mainte-
nance and patterning of certain epithelia. This has been This commonality of organotypic mispatterning, arrived
at bywhat appear to be quite distinctive cellular pathways,noted inDrosophilamutants [9] and inmammalian cells, in
which expression of kinase inactive atypical PKC disrupts strongly suggests that proper order of fusion of the heart
primordia is a key element to the generation of the cham-tight junction structure [20]. Here, we note that embryos
with the has mutation have structural discontinuities in bers and to their assembly and alignment. In situ expres-
sion analysis using ventricular and whole-heart markersthe heart field (see Figure 2g), the retinal pigmented
Research Paper Convergent heart patterning pathways in zebrafish Peterson et al. 1489
Figure 8 [31], and therefore could deprive the migrating cells of
important information needed for the proper assembly at
the posterior end of the ring.
Small molecules have proven to be valuable tools for cell
biological studies, but their use as probes in studies of
development has been limited to a few notable examples
(e.g., retinoic acid). The limited use of small molecules
in developmental studies has been due to two factors.
First, some of the developmental model systems possess
mechanisms that limit their susceptibility to small mole-
cules. For example, the mammalian placenta and the C.
elegans cuticle prevent many small molecules from reach-
ing the developing embryo. This appears to be less of an
impediment using zebrafish embryos. Second, many of
the small molecules used in cell biological studies areA model for chamber patterning in the zebrafish heart based on in
natural products. These small molecules are often pro-situ expression analysis (see the Supplementary material available
with this article online). Normally, the bilateral primordia of the heart duced by plants and microorganisms to inhibit the growth
field converge and fuse first at the posterior end and then at the anterior of competing microorganisms, so they target fundamental
end to form a cone. The cone then rotates to orient atrial precursors
cellular processes. Producing small molecule modulatorstoward the anterior and ventricular precursors toward the posterior in
of complex processes like organogenesis may be less ad-an extended heart tube. In concentramide-treated and has mutant
embryos, the fusion order of the ends of the heart field is reversed, vantageous to a microorganism, and fewer natural prod-
proceeding from the anterior to the posterior end. Rotation of the cone ucts of this sort exist. Recent technological advances are
is blocked, preventing formation of the heart tube and causing the
expanding the armamentarium of small molecules for useconcentric heart chamber phenotype. Presumptive atrial precursor cells
are colored red, ventricular precursor cells are colored blue. Views in developmental studies. The techniques of modern syn-
are dorsal; anterior is oriented up. thetic chemistry, including combinatorial chemistry, have
increased the number of potential developmentalmodula-
tors available, decreasing reliance on functionally biased
natural products (reviewed in [7, 39]).
suggests that medial cells of the bilateral heart field are
destined to become ventricle, while lateral cells are des-
tined to become atrium ([32] and data not shown). In Obviously, disruptions by small molecules may speak im-
wild-type embryos, fusion of the heart field proceeds from portantly to toxicological effects upon development. They
posterior to anterior, transiently forming a concentric might help to categorize and collate the growing compen-
structure with ventricular cells along the inside of the ring dium of biologically active molecules, based upon concat-
(Figure 8). This structure rapidly undergoes a 90 rotation, enations of in vivo phenotypes. Yet it has been unclear
forming the heart tube. In both concentramide-treated how informative such screens might be about normal de-
and has mutant embryos, heart field fusion proceeds from velopment. We believe that, as shown here for con-
anterior to posterior, and rotation of the heart ring to centramide, small molecule modulators are likely to be
form a tube does not occur (Figure 8). We assume that most informative when they combine great potency and
ventricular cells need to assemble at the posterior end of specificity and are used to complement mutational analy-
the ring at the right time and, if blocked in this midline sis. We are developing techniques to identify the molecu-
convergence, can later maintain their cell fates and fashion lar target of concentramide, and we expect that technolog-
a chamber, but one disoriented with regard to the atrium. ical improvements will continue to simplify the process
The anterior and posterior ends of the heart field are of identifying other small molecule targets [40]. As small
quite different in patterns of genes expressed, in part molecules and their targets become easier to identify,
attributable to the proximity to the notochord, so the they will become useful conditional probes for dissecting
process of chambermorphogenesis could certainly require organogenesis and other complex integrative biological
exposure to exquisitely timed signals from neighboring processes as well.
structures [1, 38]. This could be deficient in has due to
intrinsic heart primordial defects, as demonstrated by the
Materials and methodspatchy expression of cmlc2 and concordant with more
Small molecule treatmentwidespread epithelial dysfunction, or due to aberrant sig-
Zebrafish were maintained at 28.5C as described [41]. Unless specifiednals from the overlying defective neural plate. Con- otherwise, embryos were treated prior to gastrulation by adding con-
centramide causes anterior displacement of the heart field centramide to the egg water at a final concentration of 34 nM from a
34-M stock solution in DMSO.relative to other signaling centers, including the notochord
1490 Current Biology Vol 11 No 19
(ventricle) probes is available at http://images.cellpress.com/supmat/Whole-mount in situ hybridization and immunohistochemistry
supmatin.htm.Digoxigenin-labeled antisense RNA probes were generated by in vitro
transcription for cmlc2 [32], vmhc [32], ntl [42], -tropomyosin [43],
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